col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


39 Results       Page 1

 [1] 
Wiley: Movement Disorders
  original article Date Title Authors   All Authors
1 [GO] 2022―May―17 COVID-19 infection enhances susceptibility to oxidative-stress induced parkinsonism Richard J. Smeyne, Jeffrey B. Eells, Debotri Chatterjee, Matthew Byrne, Shaw M. Akula, Srinivas Sriramula, et al. (+2)
2 [GO] 2021―Nov―17 Functional movement disorders during the COVID -19 pandemic: back to Charcot’s era at the Salpetriere M. Machado, C. Tarrano, F. Mesrati, E. Roze, M. Vidailhet, M. Aubignat
3 [GO] 2021―Nov―14 SARS-CoV-2 Vaccines and Motor Symptoms in Parkinson's Disease Carlos Cosentino, Luis Torres, Miriam Vélez, Yesenia Nuñez, Danilo Sánchez, Cintia Armas, Marcela Alvarado
4 [GO] 2021―Sep―24 Pandemic Tic-like Behaviors Following Social Media Consumption Theresa Paulus, Tobias Bäumer, Julius Verrel, Anne Weissbach, Veit Roessner, Christian Beste, Alexander Münchau
5 [GO] 2021―Sep―16 Impact of SARS-CoV-2 Infection in Spinocerebellar Ataxia 12 patients Inder Singh, Vishnu Swarup, Sunil Shakya, Vikash Kumar, Deepika Gupta, Roopa Rajan, et al. (+3)
6 [GO] 2021―Sep―09 Impact of COVID-19 on patient care, training and research in movement disorders in MDS-AOS region Shweta Prasad, Hrishikesh Kumar, Roongroj Bhidayasiri, Pramod Kumar Pal
7 [GO] 2021―Aug―25 Effects of the Coronavirus Disease 2019 Pandemic on Motor Symptoms in Parkinson's Disease: An Observational Study Mitsuhiro Kainaga, Yuichiro Shirota, Satoshi Kodama, Tatsushi Toda, Masashi Hamada
8 [GO] 2021―Aug―13 Rapid onset functional tic-like behaviors in young females during the COVID -19 pandemic Tamara Pringsheim, Christos Ganos, Joseph F. McGuire, Tammy Hedderly, Douglas Woods, Donald L. Gilbert, et al. (+3)
9 [GO] 2021―Aug―09 Severe dyskinesia after administration of SARS-CoV2 mRNA vaccine in Parkinson Disease Roberto Erro, Antonio Riccardo Buonomo, Paolo Barone, Maria Teresa Pellecchia
10 [GO] 2021―May―27 Covid-19 infection and Parkinsonism: is there a link? Rabia Bouali-Benazzouz, Abdelhamid Benazzouz
11 [GO] 2021―May―27 Parkinsonism as a Sequela of SARS-CoV -2 Infection: Pure Hypoxic Injury or Additional COVID-19-Related Response? Conor Fearon, David J. Mikulis, Anthony E. Lang
12 [GO] 2021―Apr―27 Patients’ perspective of dystonia symptoms during the SARS-CoV -2 pandemic Celia Delgado, Isabel Pareés, Mónica M. Kurtis
13 [GO] 2021―Apr―09 Behind the mask: recognizing facial features of Parkinson's disease during the COVID -19 pandemic. Carolina Soares, Diogo Reis Carneiro, Rafael Dias, Daniel Ferreira, Mário Sousa, Ana Oliveira, et al. (+4)
14 [GO] 2021―Mar―18 Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study Mehri Salari, Masoud Etemadifar, Alireza Zali, Aida Medghalchi, Sepand Tehrani Fateh, Zahra Aminzade, Sara Bagheri Moghaddam
15 [GO] 2021―Feb―27 Outcomes of SARS-CoV-2 Infections in Patients With Neurodegenerative Diseases in the LEOSS Cohort Meret K. Huber, Claudia Raichle, Paul Lingor, Matthis Synofzik, Stefan Borgmann, Johanna Erber, et al. (+15)
16 [GO] 2021―Feb―20 Reply to: “Parkinson's Disease and COVID-19: Do We Need to Be More Patient?” Tiago F. Outeiro, Anita Krisko
17 [GO] 2020―Oct―18 The human coronavirus receptor ANPEP (CD13) is overexpressed in Parkinson's disease. Hannah Lowes, Fiona Robertson, Angela Pyle, Rafiqul Hussain, Jon Coxhead, Alison Yarnall, et al. (+4)
18 [GO] 2020―Oct―17 Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern? Mariana H.G. Monje, Raul Martínez-Fernández
19 [GO] 2020―Oct―17 Reply to: “Can the 2019 Novel Coronavirus Cause Parkinson's Disease?” Abderrahmane Achbani, Hasnaa Sine, Aziz Naciri, Mohamed A. Baba, Ahmed Kharbach, Youssef Bouchriti, Mohamed Nejmeddine
20 [GO] 2020―Oct―07 A New Approach to the Development of Disease-Modifying Therapies for PD ; Fighting Another Pandemic Karl Kieburtz, Russell Katz, Andrew McGarry, C. Warren Olanow
21 [GO] 2020―Sep―28 Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson’s Disease Patients With COVID-19 Emanuele Cereda, Alfonso Fasano, Gianni Pezzoli
22 [GO] 2020―Sep―03 Telemedicine in movement disorders - Leçons du COVID-19 Eoin Mulroy, Elisa Menozzi, Andrew J. Lees, Timothy Lynch, Anthony E. Lang, Kailash P. Bhatia
23 [GO] 2020―Aug―24 Global survey on telemedicine utilization for movement disorders during the COVID -19 pandemic Anhar Hassan, Zoltan Mari, Emilia M. Gatto, Adriana Cardozo, Jinyoung Youn, Njideka Ok뫞jo, et al. (+75)
24 [GO] 2020―Aug―24 Impact of the COVID -19 pandemic on Functional Movement Disorders: lessons from a specialized clinic Celia Delgado, Isabel Pareés, Adolfo Jiménez-Huete, Mónica M. Kurtis
25 [GO] 2020―Aug―20 Covid-19 and Parkinsonism: A non-post-encephalitic case. Ingrid Faber, Pedro Renato P. Brandão, Fiorella Menegatti, Diógenes Diego de Carvalho Bispo, Fernando Bisinoto Maluf, Francisco Cardoso
26 [GO] 2020―Aug―12 Concerns Raised by Publication of Antonini et al., “Outcome of Parkinson Disease Patients Affected by Covid-19” Karen G. Raphael
27 [GO] 2020―Aug―12 Reply to: “Concerns Raised by Publication of Antonini et al., ‘Outcome of Parkinson Disease Patients Affected by Covid-19’” Angelo Antonini, Valentina Leta, James Teo, K. Ray Chaudhuri
28 [GO] 2020―Aug―10 Impact of COVID -19 pandemic on cognition in Parkinson's disease Giovanni Palermo, Luca Tommasini, Filippo Baldacci, Eleonora Del Prete, Gabriele Siciliano, Roberto Ceravolo
29 [GO] 2020―Aug―10 Impact of COVID -19 Pandemic on Parkinson´s Disease: A Cross-sectional Survey of 568 Spanish Patients D. Santos García, M. Oreiro, P. Pérez, G. Fanjul, J.M. Paz González, M. Feal Painceiras, et al. (+4)
30 [GO] 2020―Jun―25 Phenomenology and outcomes of in-patients with Parkinson's disease during COVID -19 pandemic Christopher Kobylecki, Theodora Jones, Cheng Khuang Lim, Carol Miller, Alexander M Thomson
31 [GO] 2020―Jun―10 The possible protective role of α-synuclein against the SARS-CoV-2 infections in patients with Parkinson's disease Sofiane Ait Wahmane, Abderrahmane Achbani, Zakaria Ouhaz, Mohamed Elatiqi, Ahmed Belmouden, Mohamed Nejmeddine
32 [GO] 2020―Jun―05 SARS-CoV -2 as a trigger of neurodegeneration: thinking ahead Tiago F. Outeiro, Anita Krisko
33 [GO] 2020―Jun―05 SARS-CoV2 as a potential trigger of neurodegenerative diseases Ulises Gomez-Pinedo, Jorge Matias-Guiu, Inmaculada Sanclemente-Alaman, Lidia Moreno-Jimenez, Paloma Montero-Escribano
34 [GO] 2020―May―25 Effects of COVID-19 on Parkinson's disease clinical features: a community-based case-control study Roberto Cilia, Salvatore Bonvegna, Giulia Straccia, Golfrè Andreasi Nico, Antonio E. Elia, Luigi M. Romito, et al. (+3)
35 [GO] 2020―May―19 Mental health, physical activity and quality of life in Parkinson's disease during COVID-19 pandemic Ali Shalash, Tamer Roushdy, Mohamed Essam, Mai Fathy, Noha L. Dawood, Eman M Abushady, et al. (+3)
36 [GO] 2020―May―12 Can the 2019 novel coronavirus cause Parkinson's disease? Abderrahmane Achbani, Hasnaa Sine, Aziz Naciri, Mohamed Amine Baba, Ahmed Kharbach, Youssef Bouchriti, Mohamed Nejmeddine
37 [GO] 2020―May―12 Incidence of Anxiety in Parkinson's Disease during Coronavirus disease ( COVID -19) pandemic Mehri Salari, Alireza Zali, Farzad Ashrafi, Masoud Etemadifar, Soumya Sharma, Nastaran Hajizadeh, Helia Ashourizadeh
38 [GO] 2020―Apr―15 SARS-CoV-2: at the crossroad between aging and neurodegeneration Alice Lippi, Renato Domingues, Cristian Setz, Tiago F. Outeiro, Anita Krisko
39 [GO] 2020―Apr―06 Impact of the COVID -19 Pandemic on Parkinson's Disease and Movement Disorders Stella M. Papa, Patrik Brundin, Victor S.C. Fung, Un Jung Kang, David J. Burn, Carlo Colosimo, et al. (+3)
 [1] 

39 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec